Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1

Low-dose interleukin-2 impairs host anti-tumor immunity and inhibits therapeutic responses in a mouse model of melanoma

(2016) Andrew Zloza et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Ten years of anti-vascular endothelial growth factor therapy

(2016) Napoleone Ferrara et al.   NATURE REVIEWS DRUG DISCOVERY

Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials

(2016) Heleen H. Van Acker et al.   PHARMACOLOGY & THERAPEUTICS

Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward?

(2016) Yu-Ling Li et al.   Cancer Biology & Medicine

IL-4 Regulates Specific Arg-1+ Macrophage sFlt-1–Mediated Inhibition of Angiogenesis

(2015) Wei-Kang Wu et al.   AMERICAN JOURNAL OF PATHOLOGY

Temporal phenotypic features distinguish polarized macrophagesin vitro

(2015) David W. Melton et al.   AUTOIMMUNITY

The Emerging Protumor Role of    T Lymphocytes: Implications for Cancer Immunotherapy

(2015) M. Rei et al.   CANCER RESEARCH

Computational systems biology approaches to anti-angiogenic cancer therapeutics

(2015) Stacey D. Finley et al.   DRUG DISCOVERY TODAY

Tumor-associated macrophages in diffuse large B-cell lymphoma

(2015) R. Kridel et al.   HAEMATOLOGICA

VEGF-A modulates expression of inhibitory checkpoints on CD8+T cells in tumors

(2015) Thibault Voron et al.   JOURNAL OF EXPERIMENTAL MEDICINE

The prognostic landscape of genes and infiltrating immune cells across human cancers

(2015) Andrew J Gentles et al.   NATURE MEDICINE

Tumor-associated macrophages in diffuse large B-cell lymphoma

(2015) R. Kridel et al.   HAEMATOLOGICA

γδ T cells for cancer immunotherapy

(2014) Jonathan PH Fisher et al.   OncoImmunology

Fcγ Receptor-induced Soluble Vascular Endothelial Growth Factor Receptor-1 (VEGFR-1) Production Inhibits Angiogenesis and Enhances Efficacy of Anti-tumor Antibodies

(2013) Steven E. Justiniano et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

VEGFA/VEGFR2-targeted therapies prevent the VEGFA-induced proliferation of regulatory T cells in cancer

(2013) Magali Terme et al.   OncoImmunology

VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2

(2012) N G Gavalas et al.   BRITISH JOURNAL OF CANCER

Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells

(2012) Lavinia Insalaco et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Tumor-promoting Versus Tumor-antagonizing Roles of γδ T Cells in Cancer Immunotherapy

(2012) Volker Kunzmann et al.   JOURNAL OF IMMUNOTHERAPY

Identification of a Novel Proinflammatory Human Skin-Homing V 9V 2 T Cell Subset with a Potential Role in Psoriasis

(2011) U. Laggner et al.   JOURNAL OF IMMUNOLOGY

Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors

(2010) Helena Pavlakovic et al.   Annals of the New York Academy of Sciences

Effect of vascular endothelial growth factor and its receptor KDR on the transendothelial migration and local trafficking of human T cells in vitro and in vivo

(2010) M. Edelbauer et al.   BLOOD

Immunity, Inflammation, and Cancer

(2010) Sergei I. Grivennikov et al.   CELL

VEGF Blockade Inhibits Lymphocyte Recruitment and Ameliorates Immune-Mediated Vascular Remodeling

(2010) Jiasheng Zhang et al.   CIRCULATION RESEARCH

Tumor-infiltrating IL-17-producing γδ T cells support the progression of tumor by promoting angiogenesis

(2010) Daiko Wakita et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

IL-10 regulation of macrophage VEGF production is dependent on macrophage polarisation and hypoxia

(2010) Wei-Kang Wu et al.   IMMUNOBIOLOGY

Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

(2010) Christian Steidl et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vascular endothelial growth factor-induced chemotaxis and IL-10 from T cells

(2009) Jin-Young Shin et al.   CELLULAR IMMUNOLOGY

Serum Vascular Endothelial Growth Factor and Fibronectin Predict Clinical Response to High-Dose Interleukin-2 Therapy

(2009) Marianna Sabatino et al.   JOURNAL OF CLINICAL ONCOLOGY

Expression of Soluble Vascular Endothelial Growth Factor Receptor-1 in Human Monocyte-Derived Mature Dendritic Cells Contributes to Their Antiangiogenic Property

(2009) M. Kishuku et al.   JOURNAL OF IMMUNOLOGY

Cutting Edge: Vascular Endothelial Growth Factor-Mediated Signaling in Human CD45RO+ CD4+ T Cells Promotes Akt and ERK Activation and Costimulates IFN-  Production

(2009) A. Basu et al.   JOURNAL OF IMMUNOLOGY

A Compartment Model of VEGF Distribution in Humans in the Presence of Soluble VEGF Receptor-1 Acting as a Ligand Trap

(2009) Florence T. H. Wu et al.   PLoS One

A compartment model of VEGF distribution in blood, healthy and diseased tissues

(2008) Marianne O Stefanini et al.   BMC Systems Biology

Immune Response of Human Propagated γδ-T-Cells to Neuroblastoma Recommend the Vδ1+ Subset for γδ-T-cell–based Immunotherapy

(2008) Karin Schilbach et al.   JOURNAL OF IMMUNOTHERAPY

Tumor Angiogenesis

(2008) Robert S. Kerbel   NEW ENGLAND JOURNAL OF MEDICINE